SGLT2 drugs like Invokana linked to increased diabetic ketoacidosis risk
A new study determined that people who take the SGLT2 inhibitor class of diabetes medications face a higher risk of ...
A new study determined that people who take the SGLT2 inhibitor class of diabetes medications face a higher risk of ...
A daily dose of news, views, opinions, and actionable information from the global healthcare industry. Our newsletter is available for a limited audience. If you are interested to write or contribute to this portal then please get in touch.
© 2025 - The Healthcare Daily